MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma

NCT03566199 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Intrinsic Pontine Glioma

Interventions

DRUG: Panobinostat Nanoparticle Formulation MTX110
DRUG: Convection-Enhanced Delivery (CED)

Sponsor

Sabine Mueller, MD, PhD

Collaborators

[object Object]
[object Object]